|
(V8) |
Myocardial blood flow and regional left ventricular longitudinal function improve with extracorporeal shock wave therapy for refractory angina |
| |
|
L. Faber, O. Lindner, N. Bogunovic, D. Hering, W. Burchert, D. Horstkotte (Bad Oeynhausen) |
|
|
Diskussion |
|
(V9) |
Feasibility of coronary physiology assessment during regadenoson hyperemia |
| |
|
V. Lachmann, C. Jung, T. Zeus, M. Kelm, F. Bönner (Düsseldorf) |
|
|
Diskussion |
|
(V10) |
Histopathological and immunohistological findings on endomyocardial biopsies in patients with coronary microvascular dysfunction assessed by intracoronary acetylcholine testing |
| |
|
H. Lindemann, I. Petrovic, S. Hill, A. Athanasiadis, H. Mahrholdt, T. Schäufele, K. Klingel, R. Kandolf, U. Sechtem, P. Ong (Stuttgart, Tübingen) |
|
|
Diskussion |
|
(V11) |
Functional coronary vasomotor abnormalities are frequent in patients with non-ST-segment elevation myocardial infarction without culprit lesion assessed by intracoronary acetylcholine testing |
| |
|
G. Pirozzolo, L. Gabriele, A. Athanasiadis, S. Hill, T. Schäufele, H. Mahrholdt, U. Sechtem, P. Ong (Stuttgart) |
|
|
Diskussion |
|
(V12) |
Relationship of inflammatory markers with myocardial and microvascular injury in reperfused ST- elevation myocardial infarctions |
| |
|
M. Reindl, S. J. Reinstadler, H.-J. Feistritzer, G. Klug, J. Mair, A. Mayr, W. Jaschke, W.-M. Franz, B. Metzler (Innsbruck, AT) |
|
|
Diskussion |
|
(V13) |
Discrepancy between Betablockers and Ranolazine, Verapamil on infarct size in a novel coronary repetitive occlusion model of the rat. Is it time for a arteriogenic specific medication ? |
| |
|
N. Güc, P. Hillmeister, N. Gatzke, A. Dülsner, E. Buschmann, I. Buschmann (Berlin, Brandenburg an der Havel) |
|
|
Diskussion |